Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/jmv.27301 http://scihub22266oqcxt.onion/10.1002/jmv.27301 34449896!8662249!34449896     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34449896&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Med+Virol 2022 ; 94 (1): 229-239 Nephropedia Template TP {{tp|p=34449896|t=2022. Prevalence and clinical outcomes of pleural effusion in COVID-19 patients: A systematic review and meta-analysis |pdf=|usr=}}{{34449896}} gab.com Text Prevalence and clinical outcomes of pleural effusion in COVID-19 patients: A systematic review and meta-analysis JO: J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=34449896 #FOAvip Observational studies indicate that pleural effusion has an association with risk and the clinical prognosis of COVID-19 disease; however, the available literature on this area is inconsistent. The objective of this systematic review and meta-analysis is to evaluate the correlation between COVID-19 disease and pleural effusion. A rigorous literature search was conducted using multiple databases. All eligible observational studies were included from around the globe. The pooled prevalence and associated 95% confidence interval (CI) were calculated using the random effect model. Mantel-Haenszel odds ratios were produced to report overall effect size using random effect models for severity and mortality outcomes. Funnel plots, Egger regression tests, and Begg-Mazumdar's rank correlation test were used to appraise publication bias. Data from 23 studies including 6234 COVID-19 patients was obtained. The overall prevalence of pleural effusion in COVID-19 patients was 9.55% (95% CI, I(2 ) = 92%). Our findings also indicated that the presence of pleural effusions associated with increased risk of severity of disease(OR = 5.08, 95% CI 3.14-8.22, I(2 ) = 77.4%) and mortality due to illness(OR = 4.53, 95% CI 2.16-9.49, I(2 ) = 66%) compared with patients without pleural effusion. Sensitivity analyses illustrated a similar effect size while decreasing the heterogeneity. No significant publication bias was evident in the meta-analysis. The presence of pleural effusion can assist as a prognostic factor to evaluate the risk of worse outcomes in COVID-19 patients hence, it is recommended that hospitalized COVID-19 patients with pleural effusion should be managed on an early basis. Twit Text FOAVip Prevalence and clinical outcomes of pleural effusion in COVID-19 patients: A systematic review and meta-analysis ????J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=34449896 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34449896 #FOAvip English Wikipedia <ref>{{Cite pmid|34449896}}</ref> Prevalence and clinical outcomes of pleural effusion in COVID-19 patients: A systematic review and meta-analysis #MMPMID34449896 Rathore SS; Hussain N; Manju AH; Wen Q; Tousif S; Avendano-Capriles CA; Hernandez-Woodbine MJ; Rojas GA; Vatsavayi P; Tera CR; Ali MA; Singh R; Saleemi S; Patel DM J Med Virol 2022[Jan]; 94 (1): 229-239 PMID34449896show ga Observational studies indicate that pleural effusion has an association with risk and the clinical prognosis of COVID-19 disease; however, the available literature on this area is inconsistent. The objective of this systematic review and meta-analysis is to evaluate the correlation between COVID-19 disease and pleural effusion. A rigorous literature search was conducted using multiple databases. All eligible observational studies were included from around the globe. The pooled prevalence and associated 95% confidence interval (CI) were calculated using the random effect model. Mantel-Haenszel odds ratios were produced to report overall effect size using random effect models for severity and mortality outcomes. Funnel plots, Egger regression tests, and Begg-Mazumdar's rank correlation test were used to appraise publication bias. Data from 23 studies including 6234 COVID-19 patients was obtained. The overall prevalence of pleural effusion in COVID-19 patients was 9.55% (95% CI, I(2 ) = 92%). Our findings also indicated that the presence of pleural effusions associated with increased risk of severity of disease(OR = 5.08, 95% CI 3.14-8.22, I(2 ) = 77.4%) and mortality due to illness(OR = 4.53, 95% CI 2.16-9.49, I(2 ) = 66%) compared with patients without pleural effusion. Sensitivity analyses illustrated a similar effect size while decreasing the heterogeneity. No significant publication bias was evident in the meta-analysis. The presence of pleural effusion can assist as a prognostic factor to evaluate the risk of worse outcomes in COVID-19 patients hence, it is recommended that hospitalized COVID-19 patients with pleural effusion should be managed on an early basis. |COVID-19/*complications/diagnosis/mortality[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Pleural Effusion/*complications/diagnosis/epidemiology[MESH] |Prevalence[MESH] |Prognosis[MESH]Prevalence and clinical outcomes of pleural effusion in COVID-19 patie(epmc).pdf DeepDyve Pubget Overpricing